NeuroTherapeutics Pharma, Inc. (NTP) is a biopharmaceutical company developing new therapies to treat pain, epilepsy, and other nervous system disorders. NTP is advancing compounds that act through a novel mechanism of action to create a new class of medicines with potential broad application across a range of neurological and neuropsychiatric conditions.
NTP’s novel mechanism increases inhibition in a new way and represents a new class of potential therapy for neurologic disorders.
A pipeline of compounds with positive, predictive, and highly significant results with a consistent lack of sedative and cognitive side effects.
